Phreesia, Inc. (LON:0A23)
London · Delayed Price · Currency is GBP · Price in USD 28.50
-0.57 (-1.96%)
Jan 31, 2025, 6:56 PM GMT
Phreesia Market Cap
Phreesia has a market cap or net worth of 524.88 million as of February 12, 2026. Its market cap has decreased by -61.66% in one year.
Market Cap
524.88M
Enterprise Value
454.45M
Revenue
352.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.50
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has decreased from 706.60M to 524.88M, a decrease of -25.72%. That is a compound annual growth rate of -4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 552.32M | -27.13% |
| Dec 31, 2025 | 757.90M | -35.12% |
| Dec 31, 2024 | 1.17B | 15.52% |
| Dec 29, 2023 | 1.01B | -28.62% |
| Dec 30, 2022 | 1.42B | -10.14% |
| Dec 31, 2021 | 1.58B | -10.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Oxford Biomedica | 998.08M |
| CVS Group | 977.97M |
| Spire Healthcare Group | 814.80M |
| Allergy Therapeutics | 718.55M |